📰 Expanded Access News
Page 17 - Expanded Access News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Expanded Access. Real-time updates on events, politics, business and more.
December 26, 2021
Mirror Biologics, Inc., a clinical stage immunotherapy company specializing in the development, manufacturing, commercialization and clinical translation of...
December 9, 2021
This Funding will be Used, in Part, to Launch an Asian Phase II/III Randomized Controlled Registration Trial for Advanced Liver Cancer in Q1/2-2022.
December 6, 2021
/PRNewswire/ -- The Duke Energy Foundation today awarded nine grants totaling $255,000 to programs that help Indiana communities grappling with mental health...
December 6, 2021
The Duke Energy Foundation today awarded nine grants totaling $255,000 to programs that help Indiana communities grappling with mental health and substance abuse needs.
December 6, 2021
/PRNewswire/ -- The Duke Energy Foundation today awarded nine grants totaling $255,000 to programs that help Indiana communities grappling with mental health...
December 6, 2021
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced it has received no...
December 2, 2021
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced...
December 2, 2021
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced...
December 2, 2021
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced...
November 4, 2021
CME Group and Google Cloud today announced a 10-year strategic partnership to accelerate CME Groups move to the cloud and transform how global derivatives markets operate with technology.